Director Mattaj comments on the Nobel Prize for Chemistry 2020
Director Iain Mattaj commented the winners of the 2020 Nobel Prize for Chemistry: “The Nobel prize awarded to Charpentier and Doudna is very well deserved. CRISPR is a typical example of a discovery which initially seemed interesting to a limited, niche group of scientists studying bacterial evolution. It has since become a fundamental tool for biology and subsequently an experimental tool for therapies linked to human health.
Genetic engineering, first achieved in 1972, is the ability to manipulate the structure and composition of DNA molecules by “cutting and pasting”. It allows us to learn what genes do, how they work and why they go wrong.
CRISPR technology has the potential to make the “dream” of genetic engineering come true: to make specific, targeted changes in the genome of any organism.
Since the breakthrough of Charpentier and Doudna, thousands of experiments have been published showing that CRISPR systems work to enable “cut and paste” experiments in the genomes of a large variety of organisms, including human cells and organoids in culture. Off-target side effects are limited and can be measured and controlled. This progress is already enabling clinical trials of the use of CRISPR in certain types of cancer treatment. Once its safety is established, the method will be applicable to many genetic disease states, and also potentially to treat parasites that infect or damage humans, like viruses.
Meanwhile, researchers are applying the method to a wide variety of questions. At Human Technopole for example, we are using it to help understand neurodevelopmental disorders, to identify promising drug targets in different cancers and to understand aspects of the evolution of the brain.”
Image credit: Nobel Media. Ill. Niklas Elmehed.
Share:
You could also like:
-
First Marie Curie Fellowships for Human Technopole
Two Human Technopole researchers have been awarded the Marie Curie postdoctoral fellowship, one of the most prestigious fellowships for early career researchers: Dr. Carlos Jiménez and Dr. Albert Navarro Gallinad. Dr. Navarro Gallinad’s research project, presented today on National Women’s Health Day, will investigate the environmental risks faced by pregnant women by analysing almost 1,000,000 births in Lombardy over the last twelve years. Dr. Jiménez will study how the spatial arrangement of nuclear proteins contributes to optimal cell functioning.
-
Human Technopole Celebrates its First PhDs
Three young scientists from Human Technopole have, for the first time since its foundation, obtained a doctoral degree while pursuing their research within the institute: Alessandro Vinceti, Davide Castaldi, and Marco Tullio Rigoli, all enrolled in the systems medicine programme of the European School of Molecular Medicine (SEMM).
-
Research and Design Converge in Milan
Milan also means research, and this year Human Technopole is taking part in the city’s promotional campaign for the Milan Design Week, which will take place from 15 to 21 April 2024.
-
HT Director’s Lectio Magistralis
Human Technopole’s Director Marino Zerial was invited last week to give the Lectio Magistralis during the inauguration ceremony of University of Genoa’s academic year 2023-2024.
-
Profiling extrachromosomal circular DNAs
A new sequencing method sheds light on the diversity and complexity of extrachromosomal circular DNAs (eccDNAs) in single cells.